SlideShare a Scribd company logo
1 of 27
Download to read offline
06.10.2016
1
Knowledge from health 
registries, cohorts, and biobanks
Professor Stein Emil Vollset, MD, DrPH
Centre for Disease Burden, Norwegian Institute of Public Health
Department of Global Public Health and Primary Care, University of Bergen
Affiliate professor, Institute for Health Metrics and Evaluation, University of Washington, Seattle
Scandic Bergen City
Register epidemiology –
the research area where Norway has an advantage
Can registries help ?
06.10.2016
2
Why engage with register research?
A short introduction to the different registries 
What are the challenges? 
‐ Scientific
‐ Bureaucratic
Presentation of national research infrastructures ‐
Health registries for research (HRR)
HRR WP: Biostatistics support
Issues* to consider in registry research
• Norway is famous for our health registries. From a research point of view their 
aim is to say something about causality. Why? Because, if you find a causal effect, 
then maybe you can intervene and prevent disease or treat people.
• But to which extent is there causal information in the registries? You could have 
the most excellent biobank, and it could be virtually useless if data are not 
collected according to a statistical design that allows causal inference. Or if there 
are numerous unmeasured confounders. Do the registry data really contain a lot 
of gold that can be mined?
• Following Judea Pearl's fundamental distinction between seeing and doing: 
Registry data are about seeing while the interventions they shall support are about 
doing. How to bridge the gap?
• The two pillars of epidemiology are the great data sources, represented by 
cohorts, registries and other data collections, and the extensive and deep 
methodological thinking. 
* Raised by professor Odd Aalen motivating a meeting on causal inference in December 2015
06.10.2016
3
Another perspective ‐ descriptive
• Epidemiology not only etiologic/causal
research
• Also: describe determinants and health status 
of the population
• Global burden of disease project
• Registries underused for such descriptive
purposes
06.10.2016
4
Global Burden of Disease Study: Levealder – begge kjønn
Norge 2013
81.4 år
15. plass
83.7 år
79.1 år
Data fra Global Burden of Disease Study 2013 – www.healthdata.org
48     50                       55                       60                      65                       70                  75                      80                84
www.healthdata.org
• Global Burden of Disease 
(GBD) 1993 prosjekt ved
Verdensbanken og Verdens
helseorganisasjon (WHO)
• WHO perioden 1998‐2003:
World Health Report  2002 
• GBD 2010 Studien startet i
2007 ved Institute for Health 
Metrics and Evaluation 
(IHME) ved University of 
Washington i Seattle
• GBD 2013 ‐ første gang for 
188 land. Publisert i Lancet 
2014‐15. 
• GBD 2015 pågår med et 
ekspertnettverk på over 1000 
forskere fra over 100 land.
• Resultater fra GBD 2013 på
nett: www.healthdata.org
2014‐15
06.10.2016
5
GBD 2013 (publisert 2014‐2015)
GBD 2013 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, 
environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic 
analysis for the Global Burden of Disease Study 2013. Lancet 2015. Published online 11 September 2015
GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability‐adjusted life years (DALYs) for 306 
diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the 
epidemiological transition. Lancet 2015. Published online 26 August 2015
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years 
lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic 
analysis for the Global Burden of Disease Study 2013. Lancet 2015. Published online 8 June
Global Burden of Disease Cancer Collaboration. The Global Burden of Cancer 2013. JAMA Oncololgy 2015. Published 
online May 28
Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all‐cause and cause‐
specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 
2013. Lancet 2015. 385; 117–171.
Christopher J L Murray, Katrina F Ortblad, Caterina Guinovart, Stephen S Lim, Timothy M Wolock, D Allen Roberts, and 
others. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a 
systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014. 384; 1005–1070.
Nicholas J Kassebaum, Amelia Bertozzi‐Villa, Megan S Coggeshall, Katya A Shackelford, Caitlyn Steiner, Kyle R Heuton, 
and others. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic 
analysis for the Global Burden of Disease Study 2013. Lancet 2014. 384; 980–1004.
Haidong Wang, Chelsea A Liddell, Matthew M Coates, Meghan D Mooney, Carly E Levitz, Austin E Schumacher, and 
others. Global, regional, and national levels of neonatal, infant, and under‐5 mortality during 1990–2013: a systematic 
analysis for the Global Burden of Disease Study 2013. Lancet 2014. 384; 957–979.
Marie Ng, Tom Fleming, Margaret Robinson, Blake Thomson, Nicholas Graetz, Christopher Margono, and others. 
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a 
systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014, 384; 766–781.
DALY
Friske leveår
Helsetap
Kreft
Dødelighet
Overvekt,
fedme
TUSENÅRSMÅL
Risiko
faktorer
Global Burden of Disease 2013: Sannsynlighet for å dø mellom eksakt alder 15 og 50 år – etter årsak – 188 land     
Norge (3.5%)
Swaziland 
(49.6%)
Data fra GBD 2013 Mortality and Causes of Death Collaborators. Lancet 2015 
06.10.2016
6
Kreft
Hjertekar
Psykiske lidelser
Muskel‐skjelett
Selvmord
Overdoser
Trafikkdød
GBD 2013
Mortality and
causes of death,
Years of life lost
(YLL)
Non‐fastal health loss,
Years lived with
disability (YLD)
DALY
(YLL+YLD)
Disease burden
attributable to
risk factors
Lancet 2015
06.10.2016
7
GBD 2013 – deaths attributable to major risk factors – Norway 2013
Blood Pressure
Diet
Tobacco
BMI
Cholesterol
Fasting glucose
Physical activity
Kidney function
Alcohol/drugs
BMD
Occupation
Other envir
Air pollution
Unsafe sex
Sexual abuse
Malnutrition
WaSH
Cardiovascular disease
Cancer
COPD
Diabetes
GBD 2013 results ‐ http://vizhub.healthdata.org/gbd‐compare/
Data needed on population distribution
of major risk factors; 
Confounders/mediators in studies of chronic
diseases and population health
0                       2000                     4000                     6000                     8000
www.healthdata.org
• Burden of disease for 195 countries and 
terriotories, 1990‐2015
• Deaths, years of life lost (YLL), non‐fatal health
loss (YLD), DALYs (=YLL+YLD)
• and burden (above metrics) attributable to 79 
risk factors
• With GBD 2015 soon to be released also
prevalence and incidence
06.10.2016
8
registries
Electronic nationwide Nordic health registries 
with national id‐number
Registry Denmark Finland Norway Sweden
Cause of death 1943 1969 1951 1952
Medical birth 1973 1987 1967 1973
Hospital
discharge
1967 (1977*) 1969 2008 1964 (1987*)
Cancer 1943 1953 1952 1958
Prescription 1995 1994 2004 2005
* Nationwide from the year in parenthesis
From Vollset & Cappelen. Registerepidemiologi.  I Laake et al. Epidemiologiske og kliniske 
forskningsmetoder. Gyldendal Akademisk 2007 [some corrections made to the original table]
06.10.2016
9
Some reasons registries are important
• Give overview of the population’s health status and 
use of resources in the health care system
• Provide outcomes/events for cohorts and biobanks
• Often RCTs (randomised clinical trials) cannot be used 
to advance knowledge
• RCTs rarely done in many medical areas where legal 
regulations do not require them (medical devices: eg.  
hip/knee‐prostheses, and others)
• Because drug trials do not have sufficient sample size
to detect side effects
Norway Health registries – gold mine?
• There is gold – but it may be hard to find !
• Often gold is made from combining many data 
sources
• Sometimes
gold may
be found
within one
register 
alone
06.10.2016
10
Papers in New England Journal of Medicine with first 
author from a Norwegian institution 1990‐2015
1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014
0.00.51.01.52.02.53.0
3
2
1
Registry based/linkage studies =  13
Randomised clinical trial            = 9   
Observational clinical study = 2   
Basic medical sciences study = 2 
Papers in New England Journal of Medicine
with first author from Norway 1990‐2014
• Search in Pub Med: norway[Affiliation] AND n‐engl‐j‐med[Journal]
• 35 hits 1990‐2015 (1 later «retracted», 2 er «sounding board» / 
commentary without human data, 6 first author from non‐
Norwegian institution)
• 26 original‐articles remain
– 1 study of NMR for cancer detection,  1 is clinical study of hepC infection in patients receiving
immunglobuliner, 1 er en studie av assay for troponin T i et materiale fra en randomisert 
studie blant hjertekar‐pasienter, 1 is description of novel dominant genetic disease
– 9 are randomised clinical trials, (7 in cardiovascular area)
– 13 of 26 articles are based on Medical birth registry, Cancer 
registry, Cause of death registry or other data sources (cohorts, 
biobanks) linked to these registries for outcome measures
06.10.2016
11
On causal information
• None of the registries we are famous for were
designed for causal inference, neither for  
etiological nor for identifying best treatments
• They are event registries and say little about
causes of the event or factors that may improve
the outcome after the event (treatment) 
• However, many clinical quality registries are
designed for causal inference (identify best 
treatment), as are cohort studies and biobanks
linked to cohorts (identify causes of disease, 
prevention opportunities)
Typology of Health Registry data
1. (see) Health care system or population events
2. (see) Population risk factors (etiologic factors; 
behavioral, metabolic, environmental/occupational), 
population gene data
3. (see) Clinical information: diagnosis with prognostic
factors, severity of disease, functional level associated
with a disease, stage of disease, genetic/metabolic
disease markers. Repeated information over time.
4. (do‐factors) Treatments, interventions, preventive 
measures, screening programs, risk factors
06.10.2016
12
Registry, cohort/biobank information
(see) Health care system or population events
Nation‐wide population‐based mandatory registries (14)
• Cause of death registry
• Cancer registry
• Population registry
• Medical Birth Registry
• Prescription registry
• Patient registry
• Cardiovascular disease registry
• Vaccination registry
• Infectious disease registries
• Primary care data [all contacts] – not registry status yet
• Unsystematic and sparse information on risk factors, 
prognostic factors, treatments (dose, duration, surgery, 
devices), functional status.
• Limited use for causal inference alone
(see/do) COHORTS/BIOBANKS
Population risk factors
(etiologic factors; behavioral,  
metabolic, environmental
/occupational), population gene 
data
Mother &Child Cohort
Cardiovascular Screening Programs
JANUS Biobank
Tromsø and HUNT cohorts
Gain value with follow‐up
Loss of value without regular
updating of exposure and 
confounder information
need regular updating(see) Clinical quality registries
(58 with national status)
Clinical information: diagnosis with
prognostic factors, severity of
disease, functional level associated
with a disease, stage of disease, 
genetic/metabolic disease markers
(do‐factors) Treatments, 
interventions, preventive 
measures, screening 
programs, risk factors
Need great detail, many events with
duration, dose, type of intervention
and intermediate results
May be found in good Clinical quality
i
Sentrale/lovhjemlede
helseregistre
› Lovhjemmel i helseregisterloven - juridisk definisjon
› Etablert av den sentrale helseforvaltningen
› Landsdekkende – Meldeplikt
› Registerformer
› Anonyme/avidentifiserte
› Pseudonyme
› Personidentifiserbare
› Samtykke
06.10.2016
13
Sentrale/lovhjemlede helseregistre
1. Dødsårsaksregisteret
2. Medisinsk fødselsregister
3. Hjerte- og karregisteret
4. Meldingssystem for smittsomme sykdommer (MSIS)
5. Nasjonalt vaksinasjonsregister
6. Resistensregistrene (NORM, RAVN)
7. Norsk overvåkingssystem for infeksjoner i sykehustjenesten (NOIS)
8. Reseptbasert legemiddelregister
9. Register over svangerskapsavbrudd
10. Kreftregisteret
11. Genetisk masseundersøkelse av nyfødte
12. Norsk pasientregister
13. Informasjonssystem for pleie og omsorgssektoren (IPLOS)
14. Forsvarets helseregister
Under etablering
1. Helsearkivregisteret
2. System for bivirkningsrapportering
Sentrale helseregistre per februar 2015
Register Etablert Owner/
ID
1. Dødsårsaksregisteret  / Cause of death Registry 1925 FHI Pid.
2. Medisinsk fødselsregister  / Medical Birth Registry 1967 FHI Pid.
3. Register for svangerskapsavbrudd  / Registry for abortions 1979 FHI deid.
4. Nasjonalt register over hjerte‐ og karlidelser / Cardiovascular disease registry 2012 FHI Pid.
5. Meldingssystem for smittsomme sykdommer (MSIS) / Surveillance system infectious diseases 1977 FHI Pid/deid
6. Nasjonalt vaksinasjonsregister (SYSVAK) / Vaccination registry 1995 FHI Pid.
7. Resistensregistrene (NORM, RAVN) / Registries for antibiotic resistance 2000 FHI deid.
8. Norsk overvåkingssystem for infeksjoner i sykehustjenesten (NOIS) / Hospital infections registry 2005 FHI deid.
9. Reseptbasert legemiddelregister / Prescription registry 2004 FHI Pseudo
10. Kreftregisteret  / Cancer Registry 1951 Kreftregisteret Pid.
11. Norsk pasientregister (NPR)  / Patient registry (hospitalisations and outpatient visits) 1997/2008Helsedir. Pid.
12. IPLOS‐registeret  2006 Helsedir. Pseudo
13. Forsvarets helseregister / Norwegian defence health registry 2005 Forsvarsdep. Pid.
14. Genetisk masseundersøkelse av nyfødte  / Genetic mass‐screening of newborns 2012 OUS Pid.
https://ehelse.no/helseregistre
National health registries 2015
06.10.2016
14
› Helse Nord RHF
› Nordisk register for hidradenitis suppurativa - HISREG
› Norsk Nakke- og Ryggregister
› Nasjonalt kvalitetsregister for ryggkirurgi
› Norsk register for arvelige og medfødte nevromuskulære
› sykdommer
› Norsk register for analinkontinens
› Norsk Register for Gastrokirurgi - NoRGast
› Norsk kvalitetsregister for behandling av spiseforstyrrelser
› - NORSPIS
› Helse Vest RHF
› Norsk kvalitetsregister for artrittsykdommer (NorArtritt)
› Det Norske Nyrebiopsiregisteret
› Nasjonalt register for organspesifikke autoimmune sykdommer
› (ROAS)
› Nasjonalt register for langtids mekanisk ventilasjon (LTMV)
 Nasjonalt register for invasiv kardiologi
 Nasjonalt register for ablasjonsbehandling og elektrofysiologi
› Norsk porfyriregister
› Norsk MS Register og biobank
› Nasjonalt korsbåndregister
› Nasjonalt hoftebruddregister
› Nasjonalt Barnehofteregister
› Nasjonalt register for leddproteser
› Nasjonalt register for kronisk obstruktiv lungesykdom (KOLS)
› Norsk kvalitetsregister for leppe- kjeve- ganespalte
› Norsk Intensivregister (NIR)
› Norsk diabetesregister for voksne
› Norsk kvalitetsregister for fedmekirurgi
› Nasjonalt Kvalitetsregister for Smertebehandling 27
52 nasjonale medisinske kvalitetsregistre (2015)
› Helse Midt RHF
› Norsk ryggmargsskaderegister - NorSCIR
 Norsk hjertesviktregister
 Norsk hjerneslagregister
 Norsk Karkirurgisk register - NORKAR
 Norsk hjerteinfarktregister
› Helse Sør-Øst RHF
 Nasjonalt register for brystkreft
 Nasjonalt register for føflekkreft
 Nasjonalt register for barnekreft
 Nasjonalt register for gynekologisk kreft
 Nasjonalt register for malignt lymfom og kronisk lymfatisk
 leukemi
 Nasjonalt register for lungekreft
 Nasjonalt register for prostatakreft (NPPC)
 Nasjonalt register for tykk- og endetarmskreft
› Norsk kvinnelig inkontinensregister (NKIR)
› Kvalitetsregister for demens
 Nasjonalt hjertestansregister
 Norsk Pacemaker og ICD-register
› Norsk kvalitetsregister for hiv (NORHIV)
› Norsk gynekologisk endoskopiregister (NGER)
› Norsk Nefrologiregister
 Det norske hjertekirurgiregisteret
› Gastronet
› Nasjonalt kvalitetsregister for døvblindhet
› Nasjonalt traumeregister
› Cerebral pareseregisteret i Norge (CPRN)
› Norsk Nyfødtmedisinsk Kvalitetsregister (NNK)
› Nasjonalt medisinsk kvalitetsregister for barne- og
› ungdomsdiabetes
Andre datasamlinger
› Fagsystemet KUHR
(Kontroll og utbetaling av helserefusjoner, HELFO) -
Primærhelsetjenesten
› Forløpsdatabasen trygd (FD-trygd, SSB)
› Sosioøkonomiske og økonomiske individdata i SSB
(inntekt, utdanning, sysselsetting, fødeland m.m.)
› Folkeregisteret (Skatteetaten)
06.10.2016
15
Norwegian arthroplasty register
• Hip replacement registry
• Treatment registry – type of hip prosthesis
• Narrow range of diagnoses: Osteoarthritis
• Follow‐up till failure (reoperation prosthesis)
• Norway register from 1987
• 164 000 primary hip prostheses followed
• 27 000 reoperations with replacements
• In 2014 more than 40 treatment combinations 
(semented, uncemented, hybrid, different brands 
and designs) – 17 cement types
Journal  Bone Joint Surg Br 1995
06.10.2016
16
Journal Bone Joint Surg Br 1995
Why does the arthroplasty registers work
[i.e. give good guidance to selecting best treatment]
• Very heterogenous treatment options, hundreds of
brands/types, brand/type combinations, cements in use
over time
• Relatively homogeneous patient group (moderate variation
in prognosis)
• Little clinical knowledge or clinical beliefs of choice of
treatment options according to prognosis of the patient
• Therefore clinical reality approximately allocates
treatments unrelated to prognosis (except may be age, that
is easily controlled for)
• Treatment choice is often made at the institutional level
06.10.2016
17
Questions that registry data can answer
[alone or in combination with other data sources]
• Trends in still births, perinatal and infant mortality
• Trends in maternal/gestational diabetes
• Trends in use of cesarean sections
• Which drugs cause congenital malformations
• Long term prognosis of low‐birth weight/prematurity
• Is assisted reproductive technology safe ?
• Sleeping position and sudden infant death syndrome
vollset ‐ health registries in norway ‐ isar – bergen – 20‐22 May 2012                                                                                                         slide  34
06.10.2016
18
Research question
How will prematurely born manage
the competitive adult society?
Is it possible to design a study
answering this question, including all
gestational ages and not only the
most immature?
Moster et al. New Engl J Med 2008
vollset  ‐ health registries in norway  ‐ isar – bergen – 20‐22 May 2012                                                     slide   35
9 Norwegian registries that provided outcomes
for the study
• The Medical Birth Registry
• The Cause of Death Register 
• The National Insurance Scheme (disabilities, ICD codes)
• The Norwegian Population Database (demography)
• The National Education Database (education, mother and 
father; proxy for social class)
• The Norwegian Tax Administration’s register (income)
• The National Employment Service’s register (employment 
status)
• The Register of Social Services (social benefits)
• The Central Criminal and Police Information Register
Moster et al. New Engl J Med 2008
vollset  ‐ health registries in norway  ‐ isar – bergen – 20‐22 May 2012                                                     slide   36
06.10.2016
19
• Year of birth 1967‐1983
• 903,402 livebirths without congenital anomalies
1 822         born at 23 to 27 weeks of gestation 
2 805                   at 28 to 30 weeks 
7 424                   at 31 to 33 weeks 
32 945                 at 34 to 36 weeks 
858 406               at 37 weeks or later
• Follow‐up through 2003 (34 years of data collection)
The Medical Birth Registry 
– Selection of study population
Moster et al. New Engl J Med 2008
vollset  ‐ health registries in norway  ‐ isar – bergen – 20‐22 May 2012                                                     slide   37
Conclusion:
• There was a highly significant association between
reduced gestational age at birth and medical
disabilities (e.g. cerebral palsy or mental retardation)
• For those without disabilities, there was a weaker, but
still significant association between preterm birth and
level of education, income, need for social security
benefits, establishing a family and having own
children, but not for unemployment or criminality.
• There was a striking dose-response relationship
between reduced gestational age and most outcomes
studied.
• Most premature children who survived without medical
disabilities functioned well as adults.
Moster et al. New Engl J Med 2008
vollset  ‐ health registries in norway  ‐ isar – bergen – 20‐22 May 2012                                                     slide   38
06.10.2016
20
Factors considered: birth weight, 
gestational age, growth retardation,
perinatal mortality in 2546 women who
had conceived both naturally and by assisted fertilisation
The Lancet 2008
Question: Does
assisted fertilisation
harm the baby ?
Key idea:
compare pregnancy 
outcomes in women 
who had singleton 
pregnancies 
conceived both 
spontaneously and 
after assisted 
fertilisation
2546 such women
identified in Medical 
Birth Registry
Irgens LM, Markestad T, Baste V, 
Schreuder P, Skjærven R, Øyen N.
Sleeping position and sudden infant 
death syndrome in Norway 1967‐91. 
Arch Dis Child 1995;72:478‐82.
Sudden infant death syndrome (SIDS) and sleeping position
Data:
• Time trend in SIDS from Medical 
Birth Registry
• Exposure from ad hoc survey in 
1992
• Time trend in retrospectively
reported sleeping position i 1992 
for the years 1970, 75, 80, 85, 89, 
90, 91 by 24438 mothers (70% 
response rate) sampled from 20 
largest maternity institutions.
• For each year and institution 250 
mothers were randomly selected
7x20x250=35000
• One page questionnaire
• 92.5% stated the were certain
about the babies sleeping position
at 3 months of age
06.10.2016
21
3. august 2011
Half the Norwegian population were
Vaccinated with Pandemrix against
«swine‐flu» H1N1 influenza A
‐ Narcolepsy ?
‐ Pregnancy complications?
vollset ‐ health registries in norway ‐ isar – bergen – 20‐22 May 2012                                                                                                         slide  41
06.10.2016
22
Population Registry of Norway
Surveillance System of Infectious
Diseases
(MSIS)
•Positive H1N1 tests
Medical Birth Registry of Norway (MBRN)
•Pregnancy outcomes
•Chronic conditions in pregnant women
Immunzation Registry
(SYSVAK)
•Vaccination status
•Date of vaksination
43
HELFO‐data 
Reimbursement of doctors
(KUHR )
•Primary care consultations
•Influensa (R80)
06.10.2016
23
Conclusion
• The natiowide population‐based (central) registries we are famous for 
(Cancer registry, Medical birth registry, Cause of death registry, 
Prescription registry, Patient registry and others) are not designed to 
contain causal information
• Quality registries, cohorts, biobanks associated with cohorts are designed
to study causes of diseases and to identify best treatments
• We need to establish data collection that can enrich the central registries
(determinants of population health, diet, smoking, blood pressure, 
cholesterol, BMI, alcohol/drugs, occupational exposure, environmental
exposure and others). These factors are also often prognostic factors
• Regular updates is needed and best done in large representative cohorts
or dedicated risk factor data collection systems
• Case‐control design is sometimes used in registry data collection to 
provide population data on risk factors (for each event – identify 1 or more 
similar persons from population)
Conclusion (cont.)
• Without large cohorts and biobanks the central registries
are of limited value for causal analysis
• Clinical Quality registries have a great potential for analysis
of treatments and prognostic factors. They need to be 
adequately sized, have sufficient follow‐up time and 
detailed information both on treatment (type, dose, 
duration, detailed information on procedures and devices) 
and general risk factors / prognostic factors.
• Information on national risk factor distributions are
necessary to compute population attributable numbers
from universal RR estimates and observed event numbers
in the population.   
• In short, we lack a risk factor registry (e.g. large living
national cohort, or system for regular risk factor data 
collection)
06.10.2016
24
Far better an approximate answer to 
the right question, which is often 
vague, than an exact answer to the 
wrong question, which can always be 
made precise. 
John W Tukey. The future of data analysis. 
Annals of Mathematical Statistics 1962;33(1), p 13.
Institutt for global helse og 
samfunnsmedisin
06.10.2016
25
Aftenposten
21. januar 2015
Institutt for global helse og 
samfunnsmedisin
forskning.no    15. mars 2015 Institutt for global helse og 
samfunnsmedisin
06.10.2016
26
Dagens medisin 9. april 2015
… Tilgang til helsedata for forsknings‐formål 
er en slik skandale: En stille skandale som 
skaper få overskrifter, men som man med 
enkle midler kunne ha rettet opp. 
Problemet er at dagens regelverk gjør det 
svært tidkrevende og kostbart å få tilgang 
til koblet infor‐masjon fra ulike register. Det 
betyr at slike koblinger i praksis gjøres langt 
sjeldnere og tregere enn man ellers kunne.
Institutt for global helse og 
samfunnsmedisin
Gråsoner
• Forskning – kvalitetssikring – helseanalyse ‐ infrastruktur
– REK avviser 25 % av søknadene med begrunnelse «faller utenfor 
Helseforskningsloven»
• Når blir et registerforskningsprosjekt et helseregister som 
krever konsesjon fra Datatilsynet 
• Hvordan håndteres behovet for koplede filer i produksjon 
av helsestatistikk eller helseanalyse (versus forskning)
• Anonyme data versus indirekte personidentifiserbare
• SSBs rolle i helseforskning som forvalter av 
sosioøkonomiske data og innvandrerbakgrunn
• Multippel saksbehandling av koplede filer 
Institutt for global helse og 
samfunnsmedisin
06.10.2016
27
Utfordring – prosjekter som krever 
kopling av mange registre, datakilder
• Det er de store prosjektene med et stort antall datakilder 
som gir internasjonalt forskningsfortrinn
• Eksempel: Helseundersøkelser, Dødsårsaksregister, 
Kreftregister, Norsk pasientregister, Medisinsk 
fødselsregister, Hjertekarregister, Reseptregister, KUHR‐
database, utdannelse (SSB), innvandrerbakgrunn (SSB)
• Krever selvstendig saksbehandling og forvaltningsvedtak i 
REK, SSB, hvert enkelt register, Datatilsyn 
• Kopling av to pseudonyme registre – lovlig men i dag i 
praksis umulig (manglende tekniske løsninger) – eksempel 
på årevis med saksbehandling
Institutt for global helse og 
samfunnsmedisin

More Related Content

What's hot

Reducing Overuse of Opioid Prescriptions in Outpatient General Surgery at Uni...
Reducing Overuse of Opioid Prescriptions in Outpatient General Surgery at Uni...Reducing Overuse of Opioid Prescriptions in Outpatient General Surgery at Uni...
Reducing Overuse of Opioid Prescriptions in Outpatient General Surgery at Uni...University of Utah
 
ANZICS S&Q 2014 - RRT: Daryl Jones on resourcing RRTs through Australasia.
ANZICS S&Q 2014 - RRT: Daryl Jones on resourcing RRTs through Australasia.ANZICS S&Q 2014 - RRT: Daryl Jones on resourcing RRTs through Australasia.
ANZICS S&Q 2014 - RRT: Daryl Jones on resourcing RRTs through Australasia.ANZICS
 
Home Telehealth Monitoring Outcome Assessment - Kings Fund
Home Telehealth Monitoring Outcome Assessment - Kings FundHome Telehealth Monitoring Outcome Assessment - Kings Fund
Home Telehealth Monitoring Outcome Assessment - Kings Fundjohnstamford
 
Evidence-based medicine databases
Evidence-based medicine databasesEvidence-based medicine databases
Evidence-based medicine databasesnabot
 
ספר מחקר שערי צדק
ספר מחקר שערי צדק ספר מחקר שערי צדק
ספר מחקר שערי צדק ShaareZedek
 
Cemal H. Guvercin MedicReS 5th World Congress
Cemal H. Guvercin MedicReS 5th World Congress Cemal H. Guvercin MedicReS 5th World Congress
Cemal H. Guvercin MedicReS 5th World Congress MedicReS
 
Adaptation of evidence-based clinical practice guidelines in Alexandria Unive...
Adaptation of evidence-based clinical practice guidelines in Alexandria Unive...Adaptation of evidence-based clinical practice guidelines in Alexandria Unive...
Adaptation of evidence-based clinical practice guidelines in Alexandria Unive...Yasser Sami Abdel Dayem Amer
 
Pragmatic standardisation of clinical models - Interop19
Pragmatic standardisation of clinical models - Interop19Pragmatic standardisation of clinical models - Interop19
Pragmatic standardisation of clinical models - Interop19Silje Ljosland Bakke
 
EBM Resources for Pediatrics
EBM Resources for PediatricsEBM Resources for Pediatrics
EBM Resources for PediatricsClista Clanton
 
Koonal's Slides from the 2017 PROMs Conference
Koonal's Slides from the 2017 PROMs ConferenceKoonal's Slides from the 2017 PROMs Conference
Koonal's Slides from the 2017 PROMs ConferenceOffice of Health Economics
 
New Methods for Analysing the Distribution of 5Q 5D Observations
New Methods for Analysing the Distribution of 5Q 5D ObservationsNew Methods for Analysing the Distribution of 5Q 5D Observations
New Methods for Analysing the Distribution of 5Q 5D ObservationsOffice of Health Economics
 
The Knowledge Egg Stanford
The Knowledge Egg StanfordThe Knowledge Egg Stanford
The Knowledge Egg StanfordØystein Eiring
 
A Vision for a National Research Network
A Vision for a National Research Network A Vision for a National Research Network
A Vision for a National Research Network Brian Ahier
 
How to conduct high-quality clinical research?
How to conduct high-quality clinical research?How to conduct high-quality clinical research?
How to conduct high-quality clinical research?scanFOAM
 

What's hot (20)

Searching Umm Al-Qura University Digital Library
Searching Umm Al-Qura University Digital LibrarySearching Umm Al-Qura University Digital Library
Searching Umm Al-Qura University Digital Library
 
Reducing Overuse of Opioid Prescriptions in Outpatient General Surgery at Uni...
Reducing Overuse of Opioid Prescriptions in Outpatient General Surgery at Uni...Reducing Overuse of Opioid Prescriptions in Outpatient General Surgery at Uni...
Reducing Overuse of Opioid Prescriptions in Outpatient General Surgery at Uni...
 
ANZICS S&Q 2014 - RRT: Daryl Jones on resourcing RRTs through Australasia.
ANZICS S&Q 2014 - RRT: Daryl Jones on resourcing RRTs through Australasia.ANZICS S&Q 2014 - RRT: Daryl Jones on resourcing RRTs through Australasia.
ANZICS S&Q 2014 - RRT: Daryl Jones on resourcing RRTs through Australasia.
 
Home Telehealth Monitoring Outcome Assessment - Kings Fund
Home Telehealth Monitoring Outcome Assessment - Kings FundHome Telehealth Monitoring Outcome Assessment - Kings Fund
Home Telehealth Monitoring Outcome Assessment - Kings Fund
 
Evidence-based medicine databases
Evidence-based medicine databasesEvidence-based medicine databases
Evidence-based medicine databases
 
Using secondary sources for evidence-based clinical practice
Using secondary sources for evidence-based clinical practiceUsing secondary sources for evidence-based clinical practice
Using secondary sources for evidence-based clinical practice
 
ספר מחקר שערי צדק
ספר מחקר שערי צדק ספר מחקר שערי צדק
ספר מחקר שערי צדק
 
Cemal H. Guvercin MedicReS 5th World Congress
Cemal H. Guvercin MedicReS 5th World Congress Cemal H. Guvercin MedicReS 5th World Congress
Cemal H. Guvercin MedicReS 5th World Congress
 
BJUI study
BJUI studyBJUI study
BJUI study
 
Adaptation of evidence-based clinical practice guidelines in Alexandria Unive...
Adaptation of evidence-based clinical practice guidelines in Alexandria Unive...Adaptation of evidence-based clinical practice guidelines in Alexandria Unive...
Adaptation of evidence-based clinical practice guidelines in Alexandria Unive...
 
Pragmatic standardisation of clinical models - Interop19
Pragmatic standardisation of clinical models - Interop19Pragmatic standardisation of clinical models - Interop19
Pragmatic standardisation of clinical models - Interop19
 
EBM Resources for Pediatrics
EBM Resources for PediatricsEBM Resources for Pediatrics
EBM Resources for Pediatrics
 
Koonal's Slides from the 2017 PROMs Conference
Koonal's Slides from the 2017 PROMs ConferenceKoonal's Slides from the 2017 PROMs Conference
Koonal's Slides from the 2017 PROMs Conference
 
Executive Summary
Executive SummaryExecutive Summary
Executive Summary
 
New Methods for Analysing the Distribution of 5Q 5D Observations
New Methods for Analysing the Distribution of 5Q 5D ObservationsNew Methods for Analysing the Distribution of 5Q 5D Observations
New Methods for Analysing the Distribution of 5Q 5D Observations
 
EDS Presentation - NLTFinal
EDS Presentation - NLTFinalEDS Presentation - NLTFinal
EDS Presentation - NLTFinal
 
Hcist 2013 dm
Hcist 2013 dmHcist 2013 dm
Hcist 2013 dm
 
The Knowledge Egg Stanford
The Knowledge Egg StanfordThe Knowledge Egg Stanford
The Knowledge Egg Stanford
 
A Vision for a National Research Network
A Vision for a National Research Network A Vision for a National Research Network
A Vision for a National Research Network
 
How to conduct high-quality clinical research?
How to conduct high-quality clinical research?How to conduct high-quality clinical research?
How to conduct high-quality clinical research?
 

Viewers also liked

Do You Know Your Net Worth?
Do You Know Your Net Worth?Do You Know Your Net Worth?
Do You Know Your Net Worth?Gerstein Fisher
 
Inflation and the Long-Term Investor
Inflation and the Long-Term InvestorInflation and the Long-Term Investor
Inflation and the Long-Term InvestorGerstein Fisher
 
Sage & SalesLogix Special Issues
Sage & SalesLogix Special IssuesSage & SalesLogix Special Issues
Sage & SalesLogix Special Issues4Thought Marketing
 
Registries rolv skjaerven
Registries rolv skjaervenRegistries rolv skjaerven
Registries rolv skjaervenEPINOR
 
Merits of the Global Portfolio
Merits of the Global PortfolioMerits of the Global Portfolio
Merits of the Global PortfolioGerstein Fisher
 
IMAGINE A WORLD DEVOID OF PLANTS
IMAGINE A WORLD DEVOID OF PLANTSIMAGINE A WORLD DEVOID OF PLANTS
IMAGINE A WORLD DEVOID OF PLANTSOkpalaugo ME'buEZE
 
Human Capital and Life Insurance
Human Capital and Life InsuranceHuman Capital and Life Insurance
Human Capital and Life InsuranceGerstein Fisher
 
Clone Clone Make: a better way to build
Clone Clone Make: a better way to buildClone Clone Make: a better way to build
Clone Clone Make: a better way to buildDanHeidinga
 
Maintaining the Purchasing Power of Portfolios
Maintaining the Purchasing Power of PortfoliosMaintaining the Purchasing Power of Portfolios
Maintaining the Purchasing Power of PortfoliosGerstein Fisher
 
Bond Investing Strategy (Part 1)
Bond Investing Strategy (Part 1)Bond Investing Strategy (Part 1)
Bond Investing Strategy (Part 1)Gerstein Fisher
 

Viewers also liked (15)

Do You Know Your Net Worth?
Do You Know Your Net Worth?Do You Know Your Net Worth?
Do You Know Your Net Worth?
 
Capitalismo vs socialismo
Capitalismo vs socialismoCapitalismo vs socialismo
Capitalismo vs socialismo
 
Basic integrations
Basic integrations Basic integrations
Basic integrations
 
Inflation and the Long-Term Investor
Inflation and the Long-Term InvestorInflation and the Long-Term Investor
Inflation and the Long-Term Investor
 
Ljubljana 2008
Ljubljana 2008Ljubljana 2008
Ljubljana 2008
 
Sage & SalesLogix Special Issues
Sage & SalesLogix Special IssuesSage & SalesLogix Special Issues
Sage & SalesLogix Special Issues
 
Registries rolv skjaerven
Registries rolv skjaervenRegistries rolv skjaerven
Registries rolv skjaerven
 
International Exposure
International ExposureInternational Exposure
International Exposure
 
Merits of the Global Portfolio
Merits of the Global PortfolioMerits of the Global Portfolio
Merits of the Global Portfolio
 
IMAGINE A WORLD DEVOID OF PLANTS
IMAGINE A WORLD DEVOID OF PLANTSIMAGINE A WORLD DEVOID OF PLANTS
IMAGINE A WORLD DEVOID OF PLANTS
 
Human Capital and Life Insurance
Human Capital and Life InsuranceHuman Capital and Life Insurance
Human Capital and Life Insurance
 
Clone Clone Make: a better way to build
Clone Clone Make: a better way to buildClone Clone Make: a better way to build
Clone Clone Make: a better way to build
 
Maintaining the Purchasing Power of Portfolios
Maintaining the Purchasing Power of PortfoliosMaintaining the Purchasing Power of Portfolios
Maintaining the Purchasing Power of Portfolios
 
THE GLORIA
THE GLORIATHE GLORIA
THE GLORIA
 
Bond Investing Strategy (Part 1)
Bond Investing Strategy (Part 1)Bond Investing Strategy (Part 1)
Bond Investing Strategy (Part 1)
 

Similar to Knowledge from health registries, cohorts, and biobanks stein emilvollset

Health registries for research anja ariansen
Health registries for research anja ariansenHealth registries for research anja ariansen
Health registries for research anja ariansenEPINOR
 
Translation research-Juma Rashid
Translation research-Juma RashidTranslation research-Juma Rashid
Translation research-Juma RashidKizito Lubano
 
Databases and Coding Validation Working Group Meeting
Databases and Coding Validation Working Group MeetingDatabases and Coding Validation Working Group Meeting
Databases and Coding Validation Working Group MeetingZoe Mitchell
 
Investigation of barriers to the implementation of clinical trials in paralle...
Investigation of barriers to the implementation of clinical trials in paralle...Investigation of barriers to the implementation of clinical trials in paralle...
Investigation of barriers to the implementation of clinical trials in paralle...Dr Sarah Markham
 
Diagnostic services atlas key headlines nov 2013 -v1
Diagnostic services  atlas   key headlines nov 2013 -v1Diagnostic services  atlas   key headlines nov 2013 -v1
Diagnostic services atlas key headlines nov 2013 -v1rightcare
 
De castro _ Editorial guidelines for sex and gender equity in research (SAGER...
De castro _ Editorial guidelines for sex and gender equity in research (SAGER...De castro _ Editorial guidelines for sex and gender equity in research (SAGER...
De castro _ Editorial guidelines for sex and gender equity in research (SAGER...Paola De Castro
 
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdfAlain van Gool
 
Nicholas Black: Linking disease registry information
Nicholas Black: Linking disease registry information Nicholas Black: Linking disease registry information
Nicholas Black: Linking disease registry information Nuffield Trust
 
Severe Asthma and Biomarkers Working Group Meeting
Severe Asthma and Biomarkers Working Group MeetingSevere Asthma and Biomarkers Working Group Meeting
Severe Asthma and Biomarkers Working Group MeetingZoe Mitchell
 
John Savil - Clinical Research in Scotland - 2010
John Savil - Clinical Research in Scotland - 2010John Savil - Clinical Research in Scotland - 2010
John Savil - Clinical Research in Scotland - 2010ipposi
 
Medical Research Map for Finland
Medical Research Map for FinlandMedical Research Map for Finland
Medical Research Map for FinlandSitra / Hyvinvointi
 
Societal Challenges.pdf
Societal Challenges.pdfSocietal Challenges.pdf
Societal Challenges.pdfOlliArjamaa1
 
Strobe estudios observacionales revision
Strobe estudios observacionales revisionStrobe estudios observacionales revision
Strobe estudios observacionales revisionEduardo Sandoval
 
Strobe estudios observacionales-revision
Strobe estudios observacionales-revisionStrobe estudios observacionales-revision
Strobe estudios observacionales-revisionEduardo Sandoval
 
Kornetsky 1- Investigators' Responsibility PRINTABLE.pdf
Kornetsky 1- Investigators' Responsibility PRINTABLE.pdfKornetsky 1- Investigators' Responsibility PRINTABLE.pdf
Kornetsky 1- Investigators' Responsibility PRINTABLE.pdfHebaLatif1
 
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries" Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries" EURORDIS - Rare Diseases Europe
 
A standards-based approach to development of clinical registries
A standards-based approach to development of clinical registriesA standards-based approach to development of clinical registries
A standards-based approach to development of clinical registriesHealth Informatics New Zealand
 

Similar to Knowledge from health registries, cohorts, and biobanks stein emilvollset (20)

Health registries for research anja ariansen
Health registries for research anja ariansenHealth registries for research anja ariansen
Health registries for research anja ariansen
 
BMJ Open-2016-Kandelaki-(1)
BMJ Open-2016-Kandelaki-(1)BMJ Open-2016-Kandelaki-(1)
BMJ Open-2016-Kandelaki-(1)
 
Translation research-Juma Rashid
Translation research-Juma RashidTranslation research-Juma Rashid
Translation research-Juma Rashid
 
Databases and Coding Validation Working Group Meeting
Databases and Coding Validation Working Group MeetingDatabases and Coding Validation Working Group Meeting
Databases and Coding Validation Working Group Meeting
 
Investigation of barriers to the implementation of clinical trials in paralle...
Investigation of barriers to the implementation of clinical trials in paralle...Investigation of barriers to the implementation of clinical trials in paralle...
Investigation of barriers to the implementation of clinical trials in paralle...
 
Diagnostic services atlas key headlines nov 2013 -v1
Diagnostic services  atlas   key headlines nov 2013 -v1Diagnostic services  atlas   key headlines nov 2013 -v1
Diagnostic services atlas key headlines nov 2013 -v1
 
De castro _ Editorial guidelines for sex and gender equity in research (SAGER...
De castro _ Editorial guidelines for sex and gender equity in research (SAGER...De castro _ Editorial guidelines for sex and gender equity in research (SAGER...
De castro _ Editorial guidelines for sex and gender equity in research (SAGER...
 
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf
2023-11-09 HealthRI Biobanking day_Amsterdam_Alain van Gool.pdf
 
Nicholas Black: Linking disease registry information
Nicholas Black: Linking disease registry information Nicholas Black: Linking disease registry information
Nicholas Black: Linking disease registry information
 
Severe Asthma and Biomarkers Working Group Meeting
Severe Asthma and Biomarkers Working Group MeetingSevere Asthma and Biomarkers Working Group Meeting
Severe Asthma and Biomarkers Working Group Meeting
 
A Stocktake of New Zealand’s Healthcare Datasets
A Stocktake of New Zealand’s Healthcare DatasetsA Stocktake of New Zealand’s Healthcare Datasets
A Stocktake of New Zealand’s Healthcare Datasets
 
John Savil - Clinical Research in Scotland - 2010
John Savil - Clinical Research in Scotland - 2010John Savil - Clinical Research in Scotland - 2010
John Savil - Clinical Research in Scotland - 2010
 
Medical Research Map for Finland
Medical Research Map for FinlandMedical Research Map for Finland
Medical Research Map for Finland
 
Societal Challenges.pdf
Societal Challenges.pdfSocietal Challenges.pdf
Societal Challenges.pdf
 
Strobe estudios observacionales revision
Strobe estudios observacionales revisionStrobe estudios observacionales revision
Strobe estudios observacionales revision
 
Strobe estudios observacionales-revision
Strobe estudios observacionales-revisionStrobe estudios observacionales-revision
Strobe estudios observacionales-revision
 
Kornetsky 1- Investigators' Responsibility PRINTABLE.pdf
Kornetsky 1- Investigators' Responsibility PRINTABLE.pdfKornetsky 1- Investigators' Responsibility PRINTABLE.pdf
Kornetsky 1- Investigators' Responsibility PRINTABLE.pdf
 
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries" Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
 
A standards-based approach to development of clinical registries
A standards-based approach to development of clinical registriesA standards-based approach to development of clinical registries
A standards-based approach to development of clinical registries
 
IRDiRC: progress and expectations
IRDiRC: progress and expectationsIRDiRC: progress and expectations
IRDiRC: progress and expectations
 

More from EPINOR

Søk Master Public Health
Søk Master Public HealthSøk Master Public Health
Søk Master Public HealthEPINOR
 
Familial associations and disease risk steinar tretli
Familial associations and disease risk steinar tretliFamilial associations and disease risk steinar tretli
Familial associations and disease risk steinar tretliEPINOR
 
Norwegian cardiovascular disease registry rune kvåle
Norwegian cardiovascular disease registry rune kvåleNorwegian cardiovascular disease registry rune kvåle
Norwegian cardiovascular disease registry rune kvåleEPINOR
 
The norwegian cause of death registry christian l.ellingsen
The norwegian cause of death registry christian l.ellingsenThe norwegian cause of death registry christian l.ellingsen
The norwegian cause of death registry christian l.ellingsenEPINOR
 
Newsletter EPINOR february 2016
Newsletter EPINOR february 2016Newsletter EPINOR february 2016
Newsletter EPINOR february 2016EPINOR
 
Newsletter EPINOR january 2016
Newsletter EPINOR january 2016Newsletter EPINOR january 2016
Newsletter EPINOR january 2016EPINOR
 
Newsletter EPINOR
Newsletter EPINOR Newsletter EPINOR
Newsletter EPINOR EPINOR
 
Presentation EPINOR-lunsj
Presentation EPINOR-lunsjPresentation EPINOR-lunsj
Presentation EPINOR-lunsjEPINOR
 
Newsletter EPINOR october 2015
Newsletter EPINOR october 2015Newsletter EPINOR october 2015
Newsletter EPINOR october 2015EPINOR
 
Newsletter EPINOR march 2015
Newsletter EPINOR march 2015Newsletter EPINOR march 2015
Newsletter EPINOR march 2015EPINOR
 
Newsletter EPINOR april 2015
Newsletter EPINOR april 2015Newsletter EPINOR april 2015
Newsletter EPINOR april 2015EPINOR
 
Newsletter EPINOR may 2015
Newsletter EPINOR may 2015Newsletter EPINOR may 2015
Newsletter EPINOR may 2015EPINOR
 
Epinor presentation 24.09.2015.
Epinor presentation 24.09.2015.Epinor presentation 24.09.2015.
Epinor presentation 24.09.2015.EPINOR
 
EPINOR Abstract book 2015
EPINOR Abstract book 2015EPINOR Abstract book 2015
EPINOR Abstract book 2015EPINOR
 
EPINOR Newsletter june_2015
EPINOR Newsletter june_2015EPINOR Newsletter june_2015
EPINOR Newsletter june_2015EPINOR
 
What should a poster contain? 18.03.14
What should a poster contain? 18.03.14What should a poster contain? 18.03.14
What should a poster contain? 18.03.14EPINOR
 
Epinor Summer School abstract-book-2014
Epinor Summer School abstract-book-2014Epinor Summer School abstract-book-2014
Epinor Summer School abstract-book-2014EPINOR
 
Lecture by Professor Imre Janszky about random error.
Lecture by Professor Imre Janszky about random error. Lecture by Professor Imre Janszky about random error.
Lecture by Professor Imre Janszky about random error. EPINOR
 
Hunt presentation 08.06.2015
Hunt presentation 08.06.2015Hunt presentation 08.06.2015
Hunt presentation 08.06.2015EPINOR
 
Epinor abstract book 2014
Epinor abstract book 2014Epinor abstract book 2014
Epinor abstract book 2014EPINOR
 

More from EPINOR (20)

Søk Master Public Health
Søk Master Public HealthSøk Master Public Health
Søk Master Public Health
 
Familial associations and disease risk steinar tretli
Familial associations and disease risk steinar tretliFamilial associations and disease risk steinar tretli
Familial associations and disease risk steinar tretli
 
Norwegian cardiovascular disease registry rune kvåle
Norwegian cardiovascular disease registry rune kvåleNorwegian cardiovascular disease registry rune kvåle
Norwegian cardiovascular disease registry rune kvåle
 
The norwegian cause of death registry christian l.ellingsen
The norwegian cause of death registry christian l.ellingsenThe norwegian cause of death registry christian l.ellingsen
The norwegian cause of death registry christian l.ellingsen
 
Newsletter EPINOR february 2016
Newsletter EPINOR february 2016Newsletter EPINOR february 2016
Newsletter EPINOR february 2016
 
Newsletter EPINOR january 2016
Newsletter EPINOR january 2016Newsletter EPINOR january 2016
Newsletter EPINOR january 2016
 
Newsletter EPINOR
Newsletter EPINOR Newsletter EPINOR
Newsletter EPINOR
 
Presentation EPINOR-lunsj
Presentation EPINOR-lunsjPresentation EPINOR-lunsj
Presentation EPINOR-lunsj
 
Newsletter EPINOR october 2015
Newsletter EPINOR october 2015Newsletter EPINOR october 2015
Newsletter EPINOR october 2015
 
Newsletter EPINOR march 2015
Newsletter EPINOR march 2015Newsletter EPINOR march 2015
Newsletter EPINOR march 2015
 
Newsletter EPINOR april 2015
Newsletter EPINOR april 2015Newsletter EPINOR april 2015
Newsletter EPINOR april 2015
 
Newsletter EPINOR may 2015
Newsletter EPINOR may 2015Newsletter EPINOR may 2015
Newsletter EPINOR may 2015
 
Epinor presentation 24.09.2015.
Epinor presentation 24.09.2015.Epinor presentation 24.09.2015.
Epinor presentation 24.09.2015.
 
EPINOR Abstract book 2015
EPINOR Abstract book 2015EPINOR Abstract book 2015
EPINOR Abstract book 2015
 
EPINOR Newsletter june_2015
EPINOR Newsletter june_2015EPINOR Newsletter june_2015
EPINOR Newsletter june_2015
 
What should a poster contain? 18.03.14
What should a poster contain? 18.03.14What should a poster contain? 18.03.14
What should a poster contain? 18.03.14
 
Epinor Summer School abstract-book-2014
Epinor Summer School abstract-book-2014Epinor Summer School abstract-book-2014
Epinor Summer School abstract-book-2014
 
Lecture by Professor Imre Janszky about random error.
Lecture by Professor Imre Janszky about random error. Lecture by Professor Imre Janszky about random error.
Lecture by Professor Imre Janszky about random error.
 
Hunt presentation 08.06.2015
Hunt presentation 08.06.2015Hunt presentation 08.06.2015
Hunt presentation 08.06.2015
 
Epinor abstract book 2014
Epinor abstract book 2014Epinor abstract book 2014
Epinor abstract book 2014
 

Recently uploaded

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...jaredbarbolino94
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxEyham Joco
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersSabitha Banu
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 

Recently uploaded (20)

OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptx
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginners
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
 

Knowledge from health registries, cohorts, and biobanks stein emilvollset